# SUNOSI
> **NDA211230** · New Drug Application · Sponsor: AXSOME MALTA · Approved 2019-03-20
## Drug
- **FDA Application Number:** NDA211230
- **Application type:** New Drug Application
- **Brand name:** SUNOSI
- **Generic name:** SOLRIAMFETOL
- **Active ingredients:** SOLRIAMFETOL HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AXSOME MALTA
- **Manufacturer:** Axsome Therapeutics, Inc.
- **First approval:** 2019-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211230)
---
*AI Analytics · CC0 1.0*